![Uwe Schoenbeck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Uwe Schoenbeck
Direttore/Membro del Consiglio presso Alterome Therapeutics, Inc.
Profilo
Uwe Schoenbeck currently works at Alterome Therapeutics, Inc., as Director and Canaan Management, Inc., as Partner.
Posizioni attive di Uwe Schoenbeck
Società | Posizione | Inizio |
---|---|---|
Canaan Management, Inc.
![]() Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Investitore di Private Equity | - |
Alterome Therapeutics, Inc.
![]() Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Canaan Management, Inc.
![]() Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Finance |
Alterome Therapeutics, Inc.
![]() Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy. | Health Technology |
- Borsa valori
- Insiders
- Uwe Schoenbeck